US4144250A
(en)
*
|
1973-05-14 |
1979-03-13 |
Stauffer Chemical Company |
Herbicidal active carboxanilide derivatives
|
JPS5830302B2
(ja)
*
|
1974-04-16 |
1983-06-28 |
キツセイヤクヒンコウギヨウ カブシキガイシヤ |
シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
|
GB1484413A
(en)
*
|
1974-04-18 |
1977-09-01 |
Kissei Pharmaceutical |
Aromatic amidocarboxylic acid derivatives
|
DE2629752A1
(de)
*
|
1976-07-02 |
1978-01-05 |
Boehringer Mannheim Gmbh |
Neue carbonsaeurederivate und verfahren zu ihrer herstellung
|
JPS56135454A
(en)
*
|
1980-03-26 |
1981-10-22 |
Kissei Pharmaceut Co Ltd |
Preparation of aromatic carboxylic acid amide derivative
|
US4337270A
(en)
*
|
1980-05-21 |
1982-06-29 |
Hisamitsu Pharmaceutical Co., Inc. |
Novel anthranilic acid derivatives
|
JPS5838244A
(ja)
*
|
1981-09-01 |
1983-03-05 |
Kissei Pharmaceut Co Ltd |
核置換シンナモイルアントラニル酸塩およびその製造方法
|
US4536346A
(en)
*
|
1983-05-06 |
1985-08-20 |
American Cyanamid Company |
Aralkanamidophenyl compounds
|
JPS6097946A
(ja)
*
|
1983-11-01 |
1985-05-31 |
Ono Pharmaceut Co Ltd |
カルボキサミド誘導体
|
JPS60116657A
(ja)
*
|
1983-11-30 |
1985-06-24 |
Ono Pharmaceut Co Ltd |
アニリン誘導体
|
JPS60142936A
(ja)
*
|
1983-12-28 |
1985-07-29 |
Ono Pharmaceut Co Ltd |
置換フエニル誘導体
|
JPS60146856A
(ja)
*
|
1983-12-30 |
1985-08-02 |
Kissei Pharmaceut Co Ltd |
α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
|
JPS60146857A
(ja)
*
|
1983-12-30 |
1985-08-02 |
Kissei Pharmaceut Co Ltd |
α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
|
IT1196348B
(it)
*
|
1984-11-29 |
1988-11-16 |
Italfarmaco Spa |
Composti ad attivita'antiinfiammatoria
|
JPH078851B2
(ja)
*
|
1985-07-29 |
1995-02-01 |
鐘淵化学工業株式会社 |
3−フエニルチオメチルスチレン誘導体
|
JPH0733357B2
(ja)
*
|
1986-09-30 |
1995-04-12 |
日本レダリ−株式会社 |
ケイ皮酸誘導体
|
JPH0692353B2
(ja)
*
|
1987-05-26 |
1994-11-16 |
マルコ製薬株式会社 |
新規なアミノ安息香酸アミド誘導体およびその製造法
|
JP2632732B2
(ja)
*
|
1989-11-06 |
1997-07-23 |
株式会社興人 |
N―(3’,4’―ジメトキシシンナモイル)アントラニル酸の製造方法
|
US6515009B1
(en)
*
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
JP2617407B2
(ja)
*
|
1992-09-14 |
1997-06-04 |
キッセイ薬品工業株式会社 |
血管内膜細胞過剰増殖疾患の予防および治療剤
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5770609A
(en)
*
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6395494B1
(en)
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6663881B2
(en)
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5595722A
(en)
*
|
1993-01-28 |
1997-01-21 |
Neorx Corporation |
Method for identifying an agent which increases TGF-beta levels
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
JPH08510451A
(ja)
*
|
1993-05-13 |
1996-11-05 |
ネオルックス コーポレイション |
異常増殖性平滑筋細胞に関連した病因の予防及び治療
|
US20030083733A1
(en)
*
|
1997-10-10 |
2003-05-01 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US20020091433A1
(en)
*
|
1995-04-19 |
2002-07-11 |
Ni Ding |
Drug release coated stent
|
US5837313A
(en)
*
|
1995-04-19 |
1998-11-17 |
Schneider (Usa) Inc |
Drug release stent coating process
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
AU6277396A
(en)
*
|
1995-06-07 |
1996-12-30 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
|
AU1618697A
(en)
*
|
1996-02-06 |
1997-08-28 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
US6019104A
(en)
*
|
1996-12-30 |
2000-02-01 |
Kissei Pharmaceutical Co., Ltd. |
Method for the treatment or prevention of restenosis associated with coronary intervention
|
DE19935219A1
(de)
|
1999-07-27 |
2001-02-01 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
|
DE10065043A1
(de)
*
|
2000-12-23 |
2002-07-04 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung
|
DE10065042A1
(de)
*
|
2000-12-23 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
|
US6613083B2
(en)
*
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
EP1318141A1
(en)
*
|
2001-12-04 |
2003-06-11 |
Dsm Nv |
Process for treating an aqueous medium containing phosphate, cyclohexanone and cyclohexanone oxime
|
JP4138659B2
(ja)
*
|
2001-12-04 |
2008-08-27 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
シクロヘキサノンオキシムおよびシクロヘキサノンを含む水性媒体を処理する方法
|
MXPA04005427A
(es)
*
|
2001-12-10 |
2005-04-19 |
Amgen Inc |
Ligandos de receptor vainilloide y su uso en tratamientos.
|
US7482488B2
(en)
*
|
2002-08-29 |
2009-01-27 |
Temple University - Of The Commonwealth System Of Higher Education |
Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
|
DE10254872A1
(de)
|
2002-11-25 |
2004-06-03 |
Symrise Gmbh & Co. Kg |
Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
|
WO2005110392A1
(en)
*
|
2004-05-14 |
2005-11-24 |
The University Of Melbourne |
Methods of modulating flt3 activity
|
CA2594460A1
(en)
|
2005-01-14 |
2006-07-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
A method of modulating t cell functioning
|
ITMI20050261A1
(it)
*
|
2005-02-21 |
2006-08-22 |
Carlo Ghisalberti |
Analoghi strutturali di avenatramidi loro uso in composizioni utili nel trattamento di disordini dermatologici
|
EP1886662B1
(de)
*
|
2006-06-14 |
2014-04-09 |
Symrise AG |
Antimikrobiell wirksame Verbindungen zur Behandlung von Mundgeruch
|
ES2462925T3
(es)
*
|
2006-06-14 |
2014-05-26 |
Symrise Ag |
Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
|
MX352516B
(es)
*
|
2006-07-05 |
2017-04-06 |
Fibrotech Therapeutics Pty Ltd |
Compuestos terapeuticos.
|
WO2008131481A1
(en)
*
|
2007-04-26 |
2008-11-06 |
Fibrotech Therapeutics Pty Ltd |
Treatment of mesangioproliferative diseases
|
EP2220028B1
(en)
*
|
2007-12-21 |
2016-03-09 |
Fibrotech Therapeutics PTY LTD |
Halogenated analogues of anti-fibrotic agents
|
WO2010071865A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
WO2010071866A2
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy for arthritis with tranilast
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
EP2455077B1
(en)
|
2009-06-17 |
2014-06-11 |
National University Corporation Kumamoto University |
Prophylactic and/or therapeutic agent for dysmenorrhea
|
JP5904944B2
(ja)
|
2009-10-22 |
2016-04-20 |
フィブロテック セラピューティクス プロプライエタリー リミテッド |
縮合環類似体の抗線維症剤
|
DE102009046115A1
(de)
*
|
2009-10-28 |
2011-09-08 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 3-Phenylpropansäuren und ihre Verwendung
|
KR101554078B1
(ko)
*
|
2011-01-25 |
2015-09-17 |
미쓰이가가쿠 아그로 가부시키가이샤 |
방향족 아미드카르본산 유도체의 제조방법
|
WO2014186737A1
(en)
*
|
2013-05-16 |
2014-11-20 |
The Johns Hopkins University |
Compositions and methods for chemical exchange saturation transfer (cest) based magnetic resonance imaging (mri)
|
CN104693063A
(zh)
*
|
2015-03-18 |
2015-06-10 |
中国药科大学制药有限公司 |
一种曲尼司特的合成方法
|
US11014873B2
(en)
|
2017-02-03 |
2021-05-25 |
Certa Therapeutics Pty Ltd. |
Anti-fibrotic compounds
|
CN110357789B
(zh)
*
|
2018-04-11 |
2022-09-30 |
华东理工大学 |
作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
|